This week in transparency news: March 30 – April 5, 2019
Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
2018 Janssen U.S. Transparency Report published –Janssen Pharmaceuticals
The recently published 2018 Janssen U.S. Transparency Report provides an inside look at the operations of Janssen Pharmaceutical Companies of Johnson & Johnson. The report notes that all 24 clinical data transparency requests with the Yale Open Data Access (YODA) project were approved in 2018.
Read the full report here
Updated trends on ClinicalTrials.gov – ClinicalTrials.gov
As of April 3, 2019, Clinicaltrials.gov contains more than 300,000 registered clinical trials. This amount already surpasses last year’s total of 293,373 registered clinical trials. The registry also tracks data on the locations and types of registered studies.
Browse the data on ClinicalTrials.gov
EudraCT releases Public Web Report for March 2019 – European Medicines Agency
The European Medicines Agency (EMA) just released the EudraCT Public Web Report for March 2019. The database recorded 56,549 clinical trials, with 79% of these clinical trials sponsored by commercial entities.
Read the full report via European Medicines Agency